Literature DB >> 17892630

Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium.

B Schulte1, A Heininger, I B Autenrieth, C Wolz.   

Abstract

During 2004 and at the start of 2005 a university hospital in Southwest Germany was affected by an extensive outbreak of vancomycin-resistant Enterococcus faecium (VRE). Although the outbreak was contained, linezolid-resistant enterococci emerged during and after the outbreak as the usage of linezolid became more common. Linezolid resistance was no longer limited to VRE. Nosocomial spread of linezolid-resistant but vancomycin-susceptible E. faecium was detected and these strains also emerged in patients without prior drug exposure. Linezolid should therefore be used with caution and the susceptibility of isolates monitored over time. Isolation precautions and screening of contacts should be considered to avoid spread of resistant isolates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892630      PMCID: PMC2870893          DOI: 10.1017/S0950268807009508

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  14 in total

1.  Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.

Authors:  Issam I Raad; Hend A Hanna; Ray Y Hachem; Tanya Dvorak; Rebecca B Arbuckle; Gassan Chaiban; Louis B Rice
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 2.  Antimicrobial resistance to linezolid.

Authors:  Venkata G Meka; Howard S Gold
Journal:  Clin Infect Dis       Date:  2004-09-10       Impact factor: 9.079

3.  Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.

Authors:  Thomas E Dobbs; Mukesh Patel; Ken B Waites; Stephen A Moser; Alan M Stamm; Craig J Hoesley
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

4.  Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.

Authors:  R D Gonzales; P C Schreckenberger; M B Graham; S Kelkar; K DenBesten; J P Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

5.  Linezolid-resistant E. faecium isolated from an open joint fracture: a report of the first isolate from Italy?

Authors:  Berit Schulte; Ingo Klare; Birgit Strommenger; Guido Werner; Ingo B Autenrieth; Christian Bahrs; Peter Heeg; Stefan Borgmann
Journal:  Int J Hyg Environ Health       Date:  2005-08-11       Impact factor: 5.840

6.  Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment.

Authors:  M G Bonora; M Ligozzi; A Luzzani; M Solbiati; E Stepan; R Fontana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

7.  Discrimination between epidemic and non-epidemic glycopeptide-resistant E. faecium in a post-outbreak situation.

Authors:  S Borgmann; B Schulte; C Wolz; H Gruber; G Werner; C Goerke; I Klare; K Beyser; P Heeg; I B Autenrieth
Journal:  J Hosp Infect       Date:  2007-07-31       Impact factor: 3.926

Review 8.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

9.  Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  Ronald N Jones; Phyllis Della-Latta; Lillian V Lee; Douglas J Biedenbach
Journal:  Diagn Microbiol Infect Dis       Date:  2002-02       Impact factor: 2.803

10.  Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.

Authors:  Sibtain Rahim; Satish K Pillai; Howard S Gold; Lata Venkataraman; Kenneth Inglima; Robert A Press
Journal:  Clin Infect Dis       Date:  2003-05-20       Impact factor: 9.079

View more
  9 in total

1.  A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium.

Authors:  Srinivas Kodali; Evgeny Vinogradov; Fiona Lin; Nancy Khoury; Li Hao; Vilo Pavliak; C Hal Jones; Diana Laverde; Johannes Huebner; Kathrin U Jansen; Annaliesa S Anderson; Robert G K Donald
Journal:  J Biol Chem       Date:  2015-06-24       Impact factor: 5.157

Review 2.  A potential role for daptomycin in enterococcal infections: what is the evidence?

Authors:  Rafael Cantón; Patricia Ruiz-Garbajosa; Ricardo L Chaves; Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2010-04-02       Impact factor: 5.790

3.  Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.

Authors:  Keith Miller; Alexander J O'Neill; Mark H Wilcox; Eileen Ingham; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

4.  Multicenter, randomized study of the efficacy and safety of intravenous iclaprim in complicated skin and skin structure infections.

Authors:  D Krievins; R Brandt; S Hawser; P Hadvary; K Islam
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

5.  Enterococcus faecium stimulates human neutrophils via the formyl-peptide receptor 2.

Authors:  Dominik Alexander Bloes; Michael Otto; Andreas Peschel; Dorothee Kretschmer
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

6.  Tedizolid Phosphate: a Next-Generation Oxazolidinone.

Authors:  Jeffrey M Rybak; Karrine Roberts
Journal:  Infect Dis Ther       Date:  2015-02-24

7.  Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.

Authors:  Laurent Dortet; Philippe Glaser; Najiby Kassis-Chikhani; Delphine Girlich; Philippe Ichai; Marc Boudon; Didier Samuel; Elodie Creton; Dilek Imanci; Rémy Bonnin; Nicolas Fortineau; Thierry Naas
Journal:  J Antimicrob Chemother       Date:  2018-01-01       Impact factor: 5.790

8.  A Case Report on Isolation of Linezolid- and Vancomycin-resistant Enterococcus faecium Species from Cerebrospinal Fluid of a Patient Suffering from Ventriculoperitoneal Shunt-associated Meningitis.

Authors:  Seema Irfan; Salima Qamar
Journal:  Cureus       Date:  2019-09-12

9.  Use of daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections: a short case series.

Authors:  Divya Pradeep Ramaswamy; Maria Amodio-Groton; Stephen J Scholand
Journal:  BMC Urol       Date:  2013-07-16       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.